
Golden Teacher mushrooms (photographer’s identification).
Mädi / Wikimedia Commons · CC BY-SA 3.0What are Golden Teacher mushrooms?
Golden Teacher is a cultivated name associated with Psilocybe cubensis. It is not a distinct mushroom species, drug molecule or standardized therapeutic product.
Also searched as: Golden Teacher · GT mushrooms
Buy Golden Teacher mushrooms: pricing & legal access
Golden Teacher mushrooms online: availability & product information
A search for Golden Teacher pricing may refer to whole mushrooms, processed products or research materials. These are different materials and should not be treated as equivalent products.
What a price alone cannot establish
- The identity or concentration of active compounds.
- Whether the listing describes the same material as another offer.
- Whether possession, supply or delivery is lawful.
DrugRX has no verified consumer pharmacy price for Golden Teacher mushrooms. This reference does not list unauthorized sellers, purchasing referrals or unverified street-price estimates.
Pricing status: No live price feed or verified quote. DrugRX does not sell or dispense products.
Sources: DEA — Controlled substances alphabetical list (October 2026)
Golden Teacher mushrooms information
Identity and cultivated naming
Golden Teacher is a name used for cultivated Psilocybe cubensis. It is not a separately established species or an approved medicine formulation.
Keep three levels separate: the fungal species, the cultivated variety name and the active chemicals. A familiar name does not authenticate a specimen’s lineage or tell you how much of a compound is present.
Scientific classification
The species reference places Psilocybe cubensis within the genus Psilocybe. Golden Teacher is a cultivated label beneath the species, rather than a separate species-level taxon.
| Rank | Classification |
|---|---|
| Kingdom | Fungi |
| Phylum | Basidiomycota |
| Class | Agaricomycetes |
| Order | Agaricales |
| Family | Hymenogastraceae |
| Genus | Psilocybe |
| Species | Psilocybe cubensis |
| Cultivated name | Golden Teacher |
Active compounds and pharmacology
Psilocybin is converted in the body to psilocin. Its psychedelic effects involve serotonin signaling. Research into a purified compound is different from research into a named mushroom variety.
- Psilocybin: a principal compound studied in psychedelic research.
- Psilocin: the active metabolite associated with psilocybin’s effects.
- Minor tryptamines: their presence and quantities depend on the tested material.
Chemical analysis of one specimen or batch should stay attached to that tested material. It cannot establish a fixed formula for every product using the same cultivated name.
Sources: NIH NCCIH — Psilocybin for mental health and addiction
Appearance and identification limits
Descriptions or photographs of mushrooms cannot establish a safe identification. Poisonous mushrooms may be mistaken for psilocybin-containing species.
A cultivated variety name is not a laboratory identification. This page does not provide a foraging key, authenticity certificate or confirmation that a particular specimen is edible.
Sources: DEA — Psilocybin
Effects and unwanted reactions
Psilocybin-containing mushrooms may alter perception, emotion and the sense of time. Responses can include significant anxiety and distress.
Possible unwanted effects
- Nausea
- Fear, panic or confusion
- Increased heart rate or blood pressure
- Impaired judgment and accident risk
The effect of a particular Golden Teacher sample cannot be predicted from its name. Severe symptoms or dangerous behavioral changes need prompt medical assessment.
Sources: NIH NCCIH — Psilocybin for mental health and addiction
Potency and chemical variability
Golden Teacher is sometimes described using informal potency labels, but there is no standardized clinical potency grade attached to the name.
A controlled study included a Jack Frost × Golden Teacher cross. Results for that cross should not be applied to every mushroom described simply as Golden Teacher. Measurements, material identity and study conditions matter.
It is not scientifically sound to assign a guaranteed effect or a universal potency multiplier based only on a cultivated label.
Sources: P. cubensis genetics and research gaps (2025) · Controlled study of 14 P. cubensis strains (2026)
Dosage and evidence limits
A measured weight of mushroom material is not a standardized amount of psilocybin. No validated Golden Teacher-specific treatment dose is established by the sources cited here.
Clinical trials use defined materials, participant screening and monitoring. Those conditions do not provide directions for using an unidentified mushroom product.
Mental health and research context
Research into psilocybin for mental health uses screened participants and controlled settings. Those findings cannot establish that a commercial variety treats depression or another condition.
People with certain psychiatric conditions may be particularly vulnerable to adverse reactions. Discuss a personal treatment question with a qualified clinician rather than relying on a variety’s marketing claims.
Sources: NIH NCCIH — Psilocybin for mental health and addiction
Legal status in the United States
Psilocybin and psilocin are federally listed in Schedule I. State or local policy changes do not automatically establish permission for consumer online delivery.
Possession, research, regulated services and distribution can be treated differently. Verify current rules for the specific activity and jurisdiction.
Sources: DEA — Controlled substances alphabetical list (October 2026)
Golden Teacher versus other cubensis varieties
Penis Envy, B+ and Albino Penis Envy are other cultivated names within the Psilocybe cubensis reference. They are not separate active chemicals.
Compare the identity and limitations of tested material rather than assuming that every example of a named variety has the same potency or clinical effect. Related variety pages are linked alongside this article.
Sources and editorial notes
Prepared by DrugRX using the references linked below. Sources were consulted on 2026-10-31. This page has not been independently reviewed by a clinician. Research findings, medication approval and legal permission are separate questions.
- P. cubensis genetics and research gaps (2025)
- NCBI Taxonomy — Psilocybe cubensis (181762)
- NIH NCCIH — Psilocybin for mental health and addiction
- DEA — Psilocybin
- Controlled study of 14 P. cubensis strains (2026)
- DEA — Controlled substances alphabetical list (October 2026)
Legal information is a dated U.S. reference. Product rules and local laws may change. Where the evidence does not establish a dose, interaction profile or price, the page states that limitation.